Closed loop with context-aware insulin delivery for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had type 1 diabetes for at least 1 year.
- You must be 18 years or older and currently using an approved hybrid closed loop system (like a Medtronic 670G, Tandem t:slim with Control-IQ, or Omnipod 5) for at least 3 months.
- Your most recent HbA1c or GMI (a measure of blood sugar control) must be between 6.5% and 10.5%.
- You must live with another adult who can sleep in the house at night and attend a training session.
- You must live within 40 miles of Oregon Health & Science University in Portland, Oregon.
- You must be physically able to do 30 minutes of exercise and not have any serious heart, kidney, or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study tests a new insulin pump system (Tandem Mobi) with a continuous glucose monitor for young athletes with type 1 diabetes. It looks at how well the system works and how it feels to use during sports.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.